Strong Organic Sales Growth
Reported organic sales growth of 7.5%, excluding COVID test sales. Growth was led by double-digit growth in medical devices and high single-digit growth in established pharmaceuticals.
Earnings Per Share Increase
Earnings per share rose to $1.30, up high single digits compared to last year and up double digits excluding the expected decline in COVID test sales.
Nutrition Segment Growth
Sales in the Nutrition segment increased by 4%, driven by 10% growth in international markets for adult nutrition products like Ensure and Glucerna.
Medical Devices Surge
Medical Devices sales grew 12.5%, with significant growth in diabetes care, electrophysiology, and cardiac rhythm management.
Strong Performance Outside China
Core Lab Diagnostics grew 7% outside of China, with markets such as the US showing an acceleration in growth.